Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo

Circulation

Volumn 93, Issue 11, 1996, Pages 2052-2058

  Münzel, Thomas ^a,b   Bassenge, Eberhard ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

circulation; Nitroglycerin; pharmacology

Indexed keywords

ANGIOTENSIN; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLYCERYL TRINITRATE; RENIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DOG; ENZYME INHIBITION; FEMALE; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRESSOR RESPONSE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASOCONSTRICTION; VASODILATATION;

EID: 0029946876     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.11.2052     Document Type: Article

References (44)

1. Abrams J. A reappraisal of nitrate therapy. JAMA. 1988;259: 396-401.
2. Elkayam U. Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention. Ann Intern Med. 1991;114:667-677.
3. Parker JD, Farrell B, Fenton T, Cohanim M, Parker JO. Counterregulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation. 1991;84:2336-2345.
4. Dupuis J, Lalonde G, Lemieux R, Rouleau J. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. J Am Coll Cardiol. 1990; 16:923-931.
5. Waldman SA, Rapoport RM, Ginsburg R, Murad F. Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem Pharmacol. 1986;35:3525-3531.
6. Schroder H, Leitman DC, Bennett BM, Waldman SA, Murad F. Glyceryl trinitrate-induced desensitization of guanylate cyclase in cultured rat lung fibroblasts. J Pharmacol Exp Ther. 1988;245: 413-418.
7. Münzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: a novel mechanism of tolerance and cross tolerance. J Clin Invest. 1995;95:187-194.
8. Münzel T, Giaid A, Kurz S, Stewart D, Harrison D. Evidence for a role of endothelin-1 and protein kinase C in nitrate tolerance. Proc Natl Acad Sci U S A. 1995;92:5244-5248.
9. Sung CP, Arleth AJ, Storer BL, Ohlstein EH. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle cells. J Pharmacol Exp Ther. 1995;271:429-437.
10. Hahn AW, Resink TJ, Scott-Burden T, Powell J, Dohi Y, Buhler FR. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regul. 1990;1: 649-659.
11. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
12. Figueras J, Lidon R, Cortadellas J. Rebound myocardial ischemia following abrupt interruption of intravenous nitroglycerin infusion in patients with unstable angina at rest. Eur Heart J. 1991;12: 405-411.
13. deMots H, Glasser SP. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Cardiol. 1989;13:186-193.
14. Franciosa JA, Nordstrom LA, Cohn JA. Nitrate therapy for congestive heart failure. JAMA. 1978;240:443-446.
15. Münzel T, Holtz J, Mülsch A, Stewart D, Bassenge E. Nitrate tolerance in epicardial arteries or in the venous system is not reversed by N-acetylcysteine in vivo, but tolerance-independent interactions exist. Circulation. 1989;79:188-197.
16. Münzel T, Mülsch A, Holtz J, Harrison DG, Bassenge E. Mechanisms of interaction between the sulfhydryl precursor L-methionine and glyceryl trinitrate. Circulation. 1992;86:995-1003.
17. Stewart DJ, Holtz J, Bassenge E. Long-term nitroglycerin treatment: effect on direct and endothelium-mediated large coronary artery dilation in conscious dogs. Circulation. 1987;75:847-856.
18. Holtz J, Held W, Sommer O, Kühne G, Bassenge E. Ergonovine-induced constrictions of epicardial coronary arteries in conscious dogs: alpha-adrenoceptors are not involved. Basic Res Cardiol. 1980;77:278-291.
19. Münzel T, Kurz S, Holtz J, Busse R, Steinhauer H, Just H, Drexler H. Neurohormonal inhibition and hemodynamic unloading during prolonged inhibition of ANF degradation in patients with severe chronic heart failure. Circulation. 1992;86:1089-1098.
20. Carmicheal P, Lieben J. Sudden death in explosive workers. Arch Environ Health. 1963;14:50-65.
21. Packer M, Meller J, Medina N, Gorlin R, Herman MV. Rebound hemodynamic events after the abrupt withdrawal of nitroprusside in patients with severe congestive heart failure. N Engl J Med. 1979; 301:1193-1197.
22. Ferratini M, Pirelli S, Merlini P, Silva P, Pollavini G. Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule. Eur Heart J. 1989; 10:998-1002.
23. Bauer JA, Fung HL. Effect of apparent elimination half-life on nitroglycerin-induced hemodynamic rebound in experimental heart failure. Pharmacol Res. 1993;10:1341-1345.
24. Parker JD, Parker AB, Farrell B, Parker JO. Intermittent transdermal nitroglycerin therapy: decreased threshold during the nitrate free interval. Circulation. 1995;91:973-978.
25. Sellke FW, Myers PR, Bates JN, Harrison DG. Influence of vessel size on the sensitivity of porcine microvessels to nitroglycerin. Am J Physiol. 1990;258:H515-H520.
26. Sellke FW, Tomanek RJ, Harrison DG. L-Cysteine selectively potentiates nitroglycerin-induced dilation of small coronary microvessels. J Pharmacol Exp Ther. 1991;258:365-369.
27. Zelis R, Mason DT. Isosorbide effect on the vasodilator response to nitroglycerin. JAMA. 1975;234:166-169.
28. Stewart DJ, Elsner D, Sommer O, Holtz J, Bassenge E. Altered spectrum of nitroglycerin action in long-term treatment: nitroglycerin-specific venous tolerance with maintenance of arterial vasode-pressor potency. Circulation. 1986;74:573-582.
29. Heitzer T, Münzel T, Just H. Nitroglycerin-induced hypersensitivity to vasoconstrictors is prevented by treatment with ACE inhibitors. Circulation. 1995;92(suppl I):I-18. Abstract.
30. 2-Adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria. Circ Res. 1994;74: 434-440.
31. Kurz S, Münzel T, Harrison DG. A role for angiotensin II in nitrate tolerance: chronic AT-1 receptor blockade prevents development of tolerance and cross tolerance. Circulation. 1995;92(suppl I):I-392. Abstract.
32. Elkayam U, Kulick D, McIntosh N, Roth A, Hsueh W, Rahimtoola SH. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. Circulation. 1987;76:577-584.
33. Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H, Dzau VJ. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res. 1993; 72:312-318.
34. Seth P, Fung HL. Biochemical characterization of a membrane-bound enzyme responsible for generating nitric oxide from nitroglycerin in vascular smooth muscle cells. Biochem Pharmacol. 1993; 46:1481-1486.
35. Wiemer G, Schölkens BA, Becker HA, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 1991;18:558-563.
36. Zanzinger J, Zheng X, Bassenge E. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism. Cardiovasc Res. 1994;28:209-214.
37. Katz RJ, Levy WS, Buff L, Wasserman AG. Prevention of nitrate tolerance with angiotensin-converting enzyme inhibitors. Circulation. 1991;83:1271-1277.
38. Boesgard S, Aldershvile J, Poulsen HE, Loft S, Anderson ME, Meister A. Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels. Circ Res. 1994;74:115-120.
39. Münzel T, Heitzer T, Kurz S, Harrison DG, Luhmann C, Pape L, Olschewski M, Just H. Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin infusion in patients with coronary artery disease. J Am Coll Cardiol. In press.
40. Mehra A, Ostrzega E, Shotan A, Johnson JV, Elkayam U. Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril. Am J Cardiol. 1992;70:1310-1314.
41. Muiesan ML, Boni E, Castellano M, Beschi M, Cefis G, Cerri B, Verdecchia P, Porcellati C, Pollavini G, Agabiti-Rosei E. Effects of transdermal nitroglycerin in combination with an ACE-inhibitor in patients with chronic stable angina pectoris. Eur Heart J. 1993;14: 1701-1708.
42. Dadak N, Makhoul N, Flugelman MY, Merdler A, Shehadeh H, Schneeweiss A, Halon DA, Lewis BS. Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1990;66:608-613.
43. Parker JD, Parker JO. Effects of therapy with an angiotensin converting enzyme inhibitor on hemodynamic and counterregulatory responses during continuous therapy with nitroglycerin. J Am Coll Cardiol. 1993;24:1445-1453.
44. Holdright DR, Katz RJ, Wright CA, Sparrow JL, Sullivan AK, Cunningham AD, Fox KM. Lack of rebound during intermittent transdermal therapy with glyceryl trinitrate in patients with stable angina on background beta blocker. Br Heart J. 1993;69:223-227.